Drug intelligence / Profile preview

azosemide

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Azosemide is a small molecule loop diuretic of the monosulfamyl class, used primarily to treat hypertension, edema (including cardiac and renal edema), ascites, and fluid overload conditions such as those associated with congestive heart failure, liver disease, and nephrotic syndrome. It acts mainly by inhibiting sodium and chloride reabsorption in both the medullary and cortical segments of the thick ascending limb of the loop of Henle in the kidney. This results in increased excretion of water, sodium, chloride, and other electrolytes. The exact molecular mechanism is not fully understood but is similar to that of furosemide; however, intravenous azosemide has a significantly greater diuretic effect than furosemide due to less first-pass metabolism. Oral bioavailability is low (~20%), with peak plasma concentrations reached within 3–4 hours after administration. The drug exhibits high protein binding (>95%) and has a terminal half-life of about 2–3 hours[1][2][5][6][7][9].

Brand names
DiartAZOSEMIDE Tablets 60mg "DSEP"
Other names
AzosemidAzosemida27589-33-9
02

Targets

NKCC2 (Sodium-potassium-chloride cotransporter 2)

Beyond the preview

Go deeper on azosemide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azosemide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call